Progestins in Hormone Replacement Therapies Reactivate Cancer Stem Cells in Women with Preexisting Breast Cancers: A Hypothesis

Perou, 2000, Molecular portraits of human breast tumours., Nature, 406, 747

Reya, 2001, Stem cells, cancer, and cancer stem cells., Nature, 414, 105

Clarke, 2006, Ovarian steroids and the human breast: regulation of stem cells and cell proliferation., Maturitas, 54, 327

Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells., Proc Natl Acad Sci USA, 100, 3983

Clarke, 2005, A putative human breast stem cell population is enriched for steroid receptor-positive cells., Dev Biol, 277, 443

Dontu, 2003, Stem cells in normal breast development and breast cancer, Cell Prolif, 36, 59

Dontu, 2004, Breast cancer, stem/progenitor cells and the estrogen receptor., Trends Endocrinol Metab, 15, 193

Sartorius, 2005, Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth., Cancer Res, 65, 9779

Horwitz, 2008, Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts., Proc Natl Acad Sci USA, 105, 5774

Rossouw, 2002, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial., JAMA, 288, 321

Beral, 2003, Breast cancer and hormone replacement therapy in the Million Women Study., Lancet, 362, 419

Fournier, 2005, Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort., Int J Cancer, 114, 448

Prentice, 2008, Estrogen plus progestin therapy and breast cancer in recently postmenopausal women., Am J Epidemiol, 167, 1207

Holmberg, 2008, Increased risk of recurrence after hormone replacement therapy in breast cancer survivors, J Natl Cancer, Institute100, 475

Santen, 2003, Risk of breast cancer with progestins: critical assessment of current data., Steroids, 68, 953

Welch, 1997, Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find?, Ann Int Med, 127, 1023

Pollei, 1987, Occult breast cancer: prevalence and radiographic detectability., Radiology, 163, 459

Ross, 2007, Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes., Clin Can Res, 13, 2831

Backman, 2005, Use of the Levonorgestrel-releasing intrauterine system and breast cancer., Obst Gynecol, 106, 813